Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
dopamine D1 receptor | 7 | 0 | 0 | 7 |
thioredoxin reductase | 39 | 0 | 0 | 39 |
GLS protein | 29 | 0 | 0 | 29 |
Thrombopoietin | 10 | 0 | 0 | 10 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 13 | 0 | 0 | 13 |
cytochrome P450 2D6 isoform 1 | 11 | 0 | 0 | 11 |
cytochrome P450 2C19 precursor | 12 | 0 | 0 | 12 |
ras-related protein Rab-9A | 10 | 0 | 0 | 10 |
histone acetyltransferase KAT2A isoform 1 | 14 | 0 | 0 | 14 |
lethal factor (plasmid) | 11 | 0 | 0 | 11 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 5 |
Spike glycoprotein | 30 | 0 | 1 | 31 |
ATP-dependent phosphofructokinase | 23 | 0 | 0 | 23 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 21 | 0 | 0 | 21 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Membrane lipoprotein tmpC | 0 | 0 | 1 | 1 |
Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
Chain A, ADENOSINE RECEPTOR A2A | 0 | 1 | 0 | 1 |
Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
AR protein | 53 | 0 | 0 | 53 |
signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 27 | 0 | 0 | 27 |
glucocorticoid receptor [Homo sapiens] | 37 | 0 | 0 | 37 |
retinoid X nuclear receptor alpha | 28 | 0 | 0 | 28 |
estrogen nuclear receptor alpha | 61 | 0 | 0 | 61 |
NPYLR7B | 0 | 0 | 4 | 4 |
arylsulfatase A | 27 | 0 | 0 | 27 |
IDH1 | 18 | 0 | 0 | 18 |
Histone H2A.x | 21 | 0 | 0 | 21 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
mitogen-activated protein kinase 1 | 12 | 0 | 0 | 12 |
flap endonuclease 1 | 11 | 0 | 0 | 11 |
nuclear receptor ROR-gamma isoform 1 | 20 | 0 | 0 | 20 |
peripheral myelin protein 22 | 29 | 0 | 0 | 29 |
survival motor neuron protein isoform d | 16 | 0 | 0 | 16 |
high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 1 | 1 |
Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel gamma-2 subunit | 20 | 0 | 0 | 20 |
Rap guanine nucleotide exchange factor 3 | 6 | 0 | 0 | 6 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 5 | 0 | 5 |
Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Avidin | 0 | 0 | 1 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Glyceraldehyde-3-phosphate dehydrogenase | 0 | 2 | 0 | 2 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
Insulin receptor | 0 | 0 | 0 | 1 |
Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
Heat shock protein HSP 90-alpha | 0 | 1 | 1 | 2 |
Platelet-derived growth factor receptor beta | 0 | 0 | 0 | 1 |
Adenosine receptor A3 | 0 | 9 | 3 | 13 |
Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
Fibroblast growth factor receptor 1 | 0 | 0 | 0 | 1 |
Inosine-5'-monophosphate dehydrogenase 2 | 0 | 1 | 0 | 1 |
Endoplasmin | 0 | 1 | 1 | 2 |
Glutamate receptor 2 | 21 | 0 | 0 | 21 |
Inosine-5'-monophosphate dehydrogenase 1 | 0 | 1 | 0 | 1 |
Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
Fibroblast growth factor receptor 4 | 0 | 0 | 0 | 1 |
Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
Streptavidin | 0 | 0 | 2 | 2 |
Adenosylhomocysteinase | 0 | 0 | 0 | 1 |
Adenosine receptor A1 | 0 | 5 | 1 | 7 |
Adenosine receptor A3 | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 6 | 5 | 13 |
Adenosine receptor A2b | 0 | 2 | 1 | 5 |
Adenosine receptor A2b | 0 | 2 | 1 | 4 |
Adenylate kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 6 | 3 | 12 |
Adenosine receptor A2a | 0 | 6 | 1 | 9 |
Adenylate kinase isoenzyme 1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase alpha | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 1 | 1 | 2 |
Adenosine kinase | 0 | 0 | 0 | 1 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 2 | 0 | 3 |
Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
Equilibrative nucleoside transporter 1 | 0 | 4 | 0 | 4 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 2 | 0 | 3 |
Solute carrier family 28 member 3 | 0 | 2 | 0 | 2 |
Adenosine kinase | 0 | 1 | 0 | 2 |
Phosphatidylinositol 4-kinase beta | 0 | 2 | 0 | 3 |
5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
Adenosine transporter 1 | 0 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 13 | 0 | 0 | 13 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 16 | 0 | 0 | 17 |
geminin | 47 | 0 | 0 | 47 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
Mineralocorticoid receptor | 0 | 5 | 3 | 9 |
Androgen receptor | 0 | 8 | 0 | 9 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 3 |
Guanine nucleotide-binding protein G | 6 | 0 | 0 | 6 |
Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 10 | 0 | 0 | 10 |
Chain B, HADH2 protein | 10 | 0 | 0 | 10 |
Chain A, 2-oxoglutarate Oxygenase | 11 | 0 | 0 | 11 |
acid sphingomyelinase | 3 | 0 | 0 | 3 |
acetylcholinesterase | 16 | 0 | 0 | 16 |
TDP1 protein | 57 | 0 | 0 | 57 |
aldehyde dehydrogenase 1 family, member A1 | 28 | 0 | 0 | 28 |
thyroid stimulating hormone receptor | 19 | 0 | 0 | 19 |
glucocerebrosidase | 6 | 0 | 0 | 6 |
alpha-galactosidase | 6 | 0 | 0 | 6 |
euchromatic histone-lysine N-methyltransferase 2 | 48 | 0 | 0 | 48 |
Bloom syndrome protein isoform 1 | 15 | 0 | 0 | 15 |
lysosomal alpha-glucosidase preproprotein | 4 | 0 | 0 | 4 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 7 | 0 | 0 | 7 |
thyroid hormone receptor beta isoform 2 | 32 | 0 | 0 | 32 |
huntingtin isoform 2 | 12 | 0 | 0 | 12 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 37 | 0 | 0 | 37 |
lamin isoform A-delta10 | 52 | 0 | 0 | 52 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 22 | 0 | 26 |
Bile salt export pump | 0 | 74 | 0 | 74 |
Prothrombin | 0 | 2 | 0 | 3 |
Coagulation factor X | 0 | 3 | 0 | 3 |
Plasminogen | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
Tissue-type plasminogen activator | 0 | 2 | 0 | 2 |
Cationic trypsin | 0 | 1 | 0 | 1 |
Coagulation factor XI | 0 | 1 | 0 | 1 |
Plasma kallikrein | 0 | 1 | 0 | 1 |
Vitamin K-dependent protein C | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 33 | 0 | 0 | 33 |
Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
Trypsin-1 | 0 | 2 | 0 | 2 |
Trypsin-2 | 0 | 2 | 0 | 2 |
Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
Sodium/hydrogen exchanger 1 | 0 | 2 | 0 | 2 |
Sodium/hydrogen exchanger 3 | 0 | 2 | 0 | 2 |
Trypsin-3 | 0 | 2 | 0 | 2 |
Amiloride-sensitive sodium channel subunit alpha | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 10 | 0 | 10 |
Sodium/hydrogen exchanger 2 | 0 | 2 | 0 | 2 |
Acid-sensing ion channel 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 36 | 0 | 36 |
Sodium channel protein type 5 subunit alpha | 0 | 18 | 0 | 18 |
Sodium/hydrogen exchanger 5 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 11 | 0 | 12 |
Solute carrier family 22 member 2 | 0 | 10 | 0 | 10 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger | 0 | 1 | 0 | 1 |
USP1 protein, partial | 17 | 0 | 0 | 17 |
Microtubule-associated protein tau | 18 | 0 | 0 | 18 |
ATP-binding cassette sub-family C member 3 | 0 | 57 | 0 | 57 |
Multidrug resistance-associated protein 4 | 0 | 57 | 0 | 59 |
Canalicular multispecific organic anion transporter 1 | 0 | 57 | 0 | 58 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 13 | 0 | 0 | 13 |
phosphopantetheinyl transferase | 17 | 0 | 0 | 17 |
hypoxia-inducible factor 1 alpha subunit | 12 | 0 | 0 | 12 |
RAR-related orphan receptor gamma | 33 | 0 | 0 | 33 |
SMAD family member 2 | 15 | 0 | 0 | 15 |
ATAD5 protein, partial | 16 | 0 | 0 | 16 |
Fumarate hydratase | 11 | 0 | 0 | 11 |
NFKB1 protein, partial | 9 | 0 | 0 | 9 |
PPM1D protein | 9 | 0 | 0 | 9 |
SMAD family member 3 | 15 | 0 | 0 | 15 |
caspase 7, apoptosis-related cysteine protease | 8 | 0 | 0 | 8 |
estrogen receptor 2 (ER beta) | 23 | 0 | 0 | 23 |
nuclear receptor subfamily 1, group I, member 3 | 30 | 0 | 0 | 30 |
progesterone receptor | 28 | 0 | 0 | 28 |
EWS/FLI fusion protein | 27 | 0 | 0 | 27 |
retinoic acid nuclear receptor alpha variant 1 | 34 | 0 | 0 | 34 |
estrogen-related nuclear receptor alpha | 44 | 0 | 0 | 44 |
farnesoid X nuclear receptor | 18 | 0 | 0 | 18 |
pregnane X nuclear receptor | 41 | 0 | 0 | 41 |
G | 23 | 0 | 0 | 23 |
cytochrome P450 2D6 | 32 | 0 | 0 | 32 |
polyprotein | 11 | 0 | 0 | 11 |
peroxisome proliferator-activated receptor delta | 19 | 0 | 0 | 19 |
peroxisome proliferator activated receptor gamma | 24 | 0 | 0 | 24 |
caspase-3 | 8 | 0 | 0 | 8 |
thyroid stimulating hormone receptor | 15 | 0 | 0 | 15 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 22 | 0 | 0 | 22 |
cellular tumor antigen p53 isoform a | 9 | 0 | 0 | 9 |
cytochrome P450 2C9 precursor | 9 | 0 | 0 | 9 |
D(1A) dopamine receptor | 18 | 0 | 0 | 18 |
chromobox protein homolog 1 | 29 | 0 | 0 | 29 |
potassium voltage-gated channel subfamily H member 2 isoform d | 20 | 0 | 0 | 20 |
heat shock protein beta-1 | 9 | 0 | 0 | 9 |
serine/threonine-protein kinase mTOR isoform 1 | 12 | 0 | 0 | 12 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 12 | 0 | 0 | 12 |
urokinase-type plasminogen activator precursor | 7 | 0 | 0 | 7 |
plasminogen precursor | 7 | 0 | 0 | 7 |
urokinase plasminogen activator surface receptor precursor | 7 | 0 | 0 | 7 |
cytochrome P450 3A4 isoform 1 | 22 | 0 | 0 | 22 |
muscarinic acetylcholine receptor M1 | 17 | 0 | 0 | 17 |
Gamma-aminobutyric acid receptor subunit pi | 22 | 4 | 6 | 32 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 9 | 0 | 0 | 9 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 10 | 0 | 10 |
Solute carrier organic anion transporter family member 1A4 | 0 | 3 | 0 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 18 | 0 | 18 |
5-hydroxytryptamine receptor 4 | 0 | 24 | 0 | 24 |
Lysine-specific demethylase PHF2 | 0 | 1 | 0 | 1 |
Interferon beta | 30 | 0 | 0 | 30 |
HLA class I histocompatibility antigen, B alpha chain | 23 | 0 | 0 | 23 |
Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
Integrin beta-3 | 7 | 1 | 0 | 8 |
Tyrosine-protein kinase Fyn | 0 | 3 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 9 | 0 | 9 |
Aldo-keto reductase family 1 member B1 | 0 | 12 | 0 | 12 |
Muscarinic acetylcholine receptor M2 | 0 | 7 | 2 | 13 |
Muscarinic acetylcholine receptor M4 | 0 | 6 | 1 | 10 |
ATP-dependent translocase ABCB1 | 0 | 27 | 3 | 45 |
Integrin alpha-IIb | 7 | 1 | 0 | 8 |
Beta-1 adrenergic receptor | 0 | 21 | 11 | 32 |
Muscarinic acetylcholine receptor M5 | 0 | 8 | 1 | 12 |
Alpha-2A adrenergic receptor | 0 | 16 | 3 | 22 |
Cytochrome P450 2C8 | 0 | 5 | 0 | 5 |
Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 9 | 2 | 15 |
Beta-3 adrenergic receptor | 0 | 12 | 11 | 23 |
D(2) dopamine receptor | 0 | 12 | 2 | 14 |
Gamma-aminobutyric acid receptor subunit beta-1 | 22 | 4 | 6 | 32 |
Alpha-1B adrenergic receptor | 0 | 15 | 1 | 16 |
Lethal factor | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 16 | 1 | 20 |
Thyroid hormone receptor beta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 22 | 4 | 6 | 32 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 22 | 4 | 6 | 32 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 22 | 4 | 6 | 32 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 22 | 4 | 6 | 32 |
Muscarinic acetylcholine receptor M3 | 0 | 9 | 2 | 14 |
ATP-dependent translocase ABCB1 | 0 | 9 | 0 | 10 |
Substance-K receptor | 0 | 4 | 0 | 4 |
D(1A) dopamine receptor | 0 | 10 | 1 | 11 |
D(4) dopamine receptor | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 22 | 4 | 6 | 32 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 22 | 4 | 6 | 32 |
Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 1 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 16 | 2 | 18 |
Histamine H2 receptor | 0 | 8 | 0 | 8 |
Endothelin-1 receptor | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 2A | 0 | 19 | 2 | 21 |
5-hydroxytryptamine receptor 2C | 0 | 26 | 2 | 28 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 22 | 4 | 6 | 32 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 22 | 4 | 6 | 32 |
Lysine-specific demethylase 5A | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 22 | 4 | 6 | 32 |
B2 bradykinin receptor | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 19 | 2 | 21 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 12 | 4 | 16 |
D(3) dopamine receptor | 0 | 14 | 0 | 14 |
Sodium channel protein type 1 subunit alpha | 0 | 7 | 0 | 7 |
Sodium channel protein type 4 subunit alpha | 0 | 10 | 0 | 12 |
Squalene synthase | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 9 | 1 | 10 |
Kappa-type opioid receptor | 0 | 11 | 2 | 13 |
5-hydroxytryptamine receptor 2B | 0 | 20 | 1 | 21 |
C-C chemokine receptor type 2 | 0 | 4 | 0 | 4 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 16 | 1 | 17 |
Histamine H2 receptor | 15 | 5 | 2 | 25 |
D(1A) dopamine receptor | 10 | 0 | 0 | 10 |
5-hydroxytryptamine receptor 6 | 0 | 15 | 1 | 16 |
Carnitine O-palmitoyltransferase 1, liver isoform | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 22 | 5 | 6 | 33 |
Gamma-aminobutyric acid receptor subunit beta-3 | 22 | 4 | 6 | 32 |
Gamma-aminobutyric acid receptor subunit beta-2 | 22 | 4 | 6 | 32 |
Sodium channel protein type 7 subunit alpha | 0 | 6 | 0 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 18 | 0 | 18 |
Sodium-dependent dopamine transporter | 0 | 13 | 1 | 14 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 18 | 0 | 18 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 22 | 0 | 23 |
Squalene monooxygenase | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 12 | 0 | 12 |
Lysine-specific demethylase 7A | 0 | 1 | 0 | 1 |
GABA theta subunit | 22 | 4 | 6 | 32 |
Carnitine O-palmitoyltransferase 1, muscle isoform | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 23 | 0 | 0 | 23 |
Sodium channel protein type 2 subunit alpha | 0 | 7 | 0 | 7 |
Ataxin-2 | 33 | 0 | 0 | 33 |
Sigma non-opioid intracellular receptor 1 | 0 | 16 | 1 | 17 |
Gamma-aminobutyric acid receptor subunit epsilon | 22 | 4 | 6 | 32 |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 1 | 1 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 8 | 0 | 8 |
Sodium channel protein type 11 subunit alpha | 0 | 6 | 0 | 6 |
Histone lysine demethylase PHF8 | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 6 | 0 | 6 |
Sodium channel protein type 10 subunit alpha | 0 | 6 | 0 | 6 |
cytochrome P450 2C9, partial | 23 | 0 | 0 | 23 |
DNA polymerase kappa isoform 1 | 10 | 0 | 0 | 10 |
Atrial natriuretic peptide receptor 3 | 0 | 2 | 0 | 2 |
Type-1A angiotensin II receptor | 0 | 5 | 2 | 7 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 6 | 0 | 6 |
Type-1 angiotensin II receptor | 0 | 5 | 4 | 11 |
Type-2 angiotensin II receptor | 0 | 5 | 0 | 5 |
Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
Chain A, Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor) | 0 | 1 | 0 | 1 |
Coagulation factor X | 0 | 1 | 0 | 1 |
neuropeptide S receptor isoform A | 7 | 0 | 0 | 7 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 6 | 0 | 0 | 6 |
hypothetical protein, conserved | 3 | 0 | 0 | 3 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 35 | 0 | 0 | 35 |
Rac1 protein | 0 | 0 | 1 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
DNA polymerase iota isoform a (long) | 17 | 0 | 0 | 17 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 7 | 0 | 7 |
Carbonic anhydrase 2 | 0 | 7 | 1 | 8 |
Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
Myeloperoxidase | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 6 | 1 | 1 | 8 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
Beta-1 adrenergic receptor | 0 | 1 | 6 | 9 |
Urease | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 21 | 15 | 37 |
5-hydroxytryptamine receptor 1A | 0 | 23 | 5 | 29 |
Alpha-1D adrenergic receptor | 0 | 9 | 2 | 15 |
Alpha-1A adrenergic receptor | 0 | 3 | 4 | 11 |
Alpha-1B adrenergic receptor | 0 | 2 | 3 | 9 |
TAR DNA-binding protein 43 | 6 | 0 | 0 | 6 |
Beta-2 adrenergic receptor | 0 | 2 | 7 | 11 |
Atrial natriuretic peptide receptor 1 | 0 | 1 | 1 | 2 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
GLI family zinc finger 3 | 42 | 0 | 0 | 42 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 4 | 0 | 0 | 4 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 1 | 6 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M5 | 0 | 3 | 1 | 6 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
activating transcription factor 6 | 19 | 0 | 0 | 19 |
67.9K protein | 15 | 0 | 0 | 15 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 25 | 0 | 0 | 25 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 22 | 0 | 0 | 22 |
Caspase-7 | 3 | 0 | 0 | 3 |
caspase-3 | 3 | 0 | 0 | 3 |
Cytochrome P450 2C9 | 0 | 26 | 0 | 26 |
Cytochrome P450 2J2 | 0 | 17 | 0 | 17 |
Inositol monophosphatase 1 | 8 | 0 | 0 | 8 |
Envelope glycoprotein | 0 | 0 | 2 | 2 |
ATPase family AAA domain-containing protein 5 | 18 | 0 | 0 | 18 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain B, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin Complex With Biotin | 0 | 0 | 1 | 1 |
Chain D, Circularly Permuted Core-streptavidin E51/a46 | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
apical membrane antigen 1, AMA1 | 4 | 0 | 0 | 4 |
nonstructural protein 1 | 0 | 1 | 0 | 1 |
green fluorescent protein, partial | 0 | 1 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 15 | 0 | 0 | 15 |
insulin-degrading enzyme isoform 1 | 0 | 0 | 1 | 1 |
Receptor-type tyrosine-protein phosphatase beta | 0 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 4 | 1 | 5 |
Chain A, Beta-lactamase | 17 | 0 | 0 | 17 |
Vpr | 3 | 0 | 0 | 3 |
Bile salt export pump | 0 | 11 | 0 | 11 |
Albumin | 0 | 0 | 3 | 3 |
Major prion protein | 0 | 0 | 2 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 4 | 0 | 4 |
Sodium channel protein type 2 subunit alpha | 0 | 4 | 0 | 4 |
Sodium channel protein type 3 subunit alpha | 0 | 4 | 0 | 4 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 3 |
Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Albumin | 0 | 2 | 6 | 12 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 4 | 0 | 5 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 4 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-b-lactamase | 0 | 0 | 0 | 1 |
BlaVIM-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 3 | 0 | 5 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 8 | 0 | 3 | 0 | 3 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 7 | 0 | 0 | 7 |
endonuclease IV | 10 | 0 | 0 | 10 |
bromodomain adjacent to zinc finger domain 2B | 7 | 0 | 0 | 7 |
peripheral myelin protein 22 isoform 1 | 11 | 0 | 0 | 11 |
M-phase phosphoprotein 8 | 9 | 0 | 0 | 9 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 4 | 0 | 4 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 4 | 0 | 4 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 8 | 0 | 8 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 6 | 0 | 6 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 8 | 0 | 8 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 9 | 0 | 10 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 4 | 0 | 4 |
Cytochrome P450 3A4 | 0 | 18 | 0 | 21 |
Cytochrome P450 2D6 | 0 | 13 | 0 | 13 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 0 | 2 | 2 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 6 | 0 | 6 |
Multidrug and toxin extrusion protein 1 | 0 | 10 | 0 | 10 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 5 | 1 | 6 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 5 | 1 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 5 | 1 | 6 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 4 | 1 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 4 | 0 | 4 |
Cytochrome P450 2D1 | 0 | 3 | 0 | 3 |
Cytochrome P450 2D26 | 0 | 3 | 0 | 3 |
Cytochrome P450 2D3 | 0 | 3 | 0 | 3 |
Delta-type opioid receptor | 0 | 6 | 0 | 6 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 3 | 0 | 3 |
Cytochrome P450 2D4 | 0 | 3 | 0 | 3 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Phosphodiesterase | 0 | 3 | 0 | 3 |
Multidrug resistance-associated protein 5 | 0 | 1 | 0 | 2 |
glp-1 receptor, partial | 15 | 0 | 0 | 15 |
LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 3 |
nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 3 | 0 | 3 |
transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 3 | 0 | 3 |
nuclear receptor coactivator 3 isoform a | 0 | 3 | 0 | 3 |
Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 3 | 0 | 4 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
Cytidine deaminase | 0 | 1 | 0 | 2 |
E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 4A | 0 | 1 | 0 | 1 |
Hypoxia-inducible factor 1-alpha | 0 | 0 | 1 | 1 |
Methylcytosine dioxygenase TET2 | 0 | 1 | 0 | 1 |
Deoxyhypusine hydroxylase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 9 | 0 | 10 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 11 | 0 | 11 |
Alpha-2C adrenergic receptor | 0 | 7 | 3 | 13 |
Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 1B | 0 | 18 | 0 | 18 |
5-hydroxytryptamine receptor 1D | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 1F | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 2B | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
Histamine H1 receptor | 0 | 3 | 0 | 3 |
Sodium-dependent serotonin transporter | 0 | 9 | 0 | 9 |
5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 5A | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 5B | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 3A | 0 | 5 | 0 | 5 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 3B | 0 | 5 | 0 | 5 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Transporter | 0 | 5 | 0 | 5 |
Histamine H3 receptor | 0 | 3 | 0 | 3 |
Chain A, Cruzipain | 6 | 0 | 0 | 6 |
STAT3, partial | 0 | 3 | 0 | 3 |
Smad3 | 10 | 0 | 0 | 10 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 13 | 0 | 0 | 13 |
nuclear receptor subfamily 1, group I, member 2 | 6 | 0 | 0 | 6 |
NPC intracellular cholesterol transporter 1 precursor | 7 | 0 | 0 | 7 |
signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 3 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 5 | 0 | 6 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 5 | 0 | 6 |
Replicase polyprotein 1ab | 0 | 8 | 1 | 9 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 3 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 3 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 5 | 0 | 6 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 3 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 3 | 0 | 4 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 3 | 0 | 4 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 3 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 4 | 0 | 0 | 4 |
PAX8 | 0 | 0 | 0 | 2 |
thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
tumor necrosis factor | 2 | 0 | 0 | 2 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 7 | 0 | 0 | 7 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 7 | 0 | 8 |
Solute carrier organic anion transporter family member 1B1 | 0 | 7 | 0 | 7 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 9 | 0 | 0 | 9 |
ADP-ribose glycohydrolase MACROD2 | 0 | 1 | 0 | 1 |
Luciferase | 10 | 0 | 0 | 10 |
aryl hydrocarbon receptor | 13 | 0 | 0 | 13 |
Aspartate aminotransferase, cytoplasmic | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 4 | 0 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 3 | 0 | 3 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 8 | 1 | 10 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 7 | 0 | 0 | 7 |
RGS12 | 1 | 0 | 0 | 1 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
DNA polymerase III, partial | 2 | 0 | 0 | 2 |
isocitrate dehydrogenase 1, partial | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 10 | 0 | 0 | 10 |
LANA | 0 | 0 | 0 | 1 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 2 | 0 | 0 | 2 |
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 5 | 0 | 0 | 5 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 4 | 0 | 0 | 4 |
serine/threonine-protein kinase PLK1 | 3 | 0 | 0 | 3 |
eyes absent homolog 2 isoform a | 3 | 0 | 0 | 3 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 2 |
snurportin-1 | 5 | 0 | 0 | 5 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 8 | 0 | 0 | 8 |
caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
kelch-like ECH-associated protein 1 | 0 | 0 | 0 | 2 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 3 | 0 | 3 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 2 | 0 | 2 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 8 | 0 | 8 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 6 | 0 | 6 |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
Caspase-7 | 2 | 0 | 0 | 2 |
Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 5 | 0 | 5 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 4 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 8 | 0 | 8 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 2 | 0 | 2 |
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
Exopolyphosphatase PRUNE1 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
Single-stranded DNA cytosine deaminase | 3 | 0 | 0 | 3 |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 2 | 0 | 2 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 3 |
GALC protein | 3 | 0 | 0 | 3 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 5 | 0 | 0 | 5 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 2 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 2 | 2 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 2 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 4 | 0 | 4 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 9 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 15 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 6 | 0 | 6 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Amyloid-beta precursor protein | 2 | 1 | 0 | 3 |
Cholinesterase | 0 | 7 | 0 | 7 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 10 | 3 | 14 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 2 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Beta-secretase 1 | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 7 | 0 | 7 |
Cholinesterase | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit epsilon | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 6 | 0 | 6 |
Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 4 | 0 | 4 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Chain A, GLUTATHIONE TRANSFERASE A1-1 | 0 | 1 | 0 | 1 |
Chain A, Glutathione S-transferase P1-1 | 0 | 1 | 0 | 1 |
Chain A, Glutathione S-transferase P1-1 | 0 | 1 | 0 | 1 |
Chain B, Glutathione S-transferase P1-1 | 0 | 1 | 0 | 1 |
Nrf2 | 1 | 0 | 0 | 1 |
WRN | 1 | 0 | 0 | 1 |
perilipin-5 | 0 | 3 | 0 | 3 |
perilipin-1 | 0 | 3 | 0 | 3 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 4 | 0 | 0 | 4 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 3 | 0 | 3 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
Hematopoietic prostaglandin D synthase | 0 | 1 | 0 | 1 |
Glutathione S-transferase A1 | 0 | 1 | 0 | 1 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Replicase polyprotein 1ab | 0 | 3 | 1 | 4 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Dual specificity mitogen-activated protein kinase kinase 6 | 0 | 1 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
UDP-glucose 4-epimerase | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
14 kDa phosphohistidine phosphatase | 0 | 2 | 0 | 2 |
large T antigen | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
Regulatory protein E2 | 0 | 0 | 1 | 1 |
DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
DNA topoisomerase 2-alpha | 0 | 1 | 1 | 7 |
DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 3 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 5 |
Caspase-3 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 1 | 5 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 1 | 5 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 1 | 5 |
DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
DNA topoisomerase 2-beta | 0 | 1 | 1 | 8 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 1 | 5 |
Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 1 | 5 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 1 | 5 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 4 | 4 |
Delta-type opioid receptor | 0 | 3 | 0 | 3 |
Mu-type opioid receptor | 0 | 6 | 1 | 7 |
Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 5 | 0 | 5 |
Mu-type opioid receptor | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 4 | 0 | 4 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 3 | 0 | 3 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
unnamed protein product | 0 | 1 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 4 | 0 | 0 | 4 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Histone deacetylase 3 | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Heme oxygenase 1 | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
Aromatase | 0 | 2 | 0 | 2 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
Heme oxygenase 2 | 0 | 1 | 0 | 1 |
Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 1 | 0 | 1 |
Cytochrome P450 144 | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Mycocyclosin synthase | 0 | 0 | 1 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 3 | 1 | 4 |
Sterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Sterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
Histone deacetylase 7 | 0 | 1 | 0 | 1 |
Histone deacetylase 2 | 0 | 1 | 0 | 1 |
Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
Histone deacetylase 11 | 0 | 1 | 0 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
Histone deacetylase 8 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Histone deacetylase 9 | 0 | 1 | 0 | 1 |
Histone deacetylase 5 | 0 | 1 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
likely tRNA 2'-phosphotransferase | 0 | 1 | 0 | 1 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
pregnane X receptor | 4 | 0 | 0 | 4 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 2 | 0 | 4 | 2 | 6 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 7 | 2 | 9 |
Alpha-2C adrenergic receptor | 0 | 7 | 2 | 9 |
Alpha-2A adrenergic receptor | 0 | 7 | 2 | 9 |
Alpha-1D adrenergic receptor | 0 | 10 | 1 | 11 |
Potassium voltage-gated channel subfamily C member 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 8 | 0 | 9 |
D(2) dopamine receptor | 0 | 5 | 1 | 6 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Transporter | 0 | 1 | 0 | 1 |
Chain A, ACETYLCHOLINESTERASE | 0 | 1 | 0 | 1 |
Chain A, Acetylcholinesterase | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 1 | 0 | 2 | 0 | 2 |
Vascular endothelial growth factor receptor 3 | 0 | 2 | 0 | 2 |
Vascular endothelial growth factor receptor 2 | 0 | 2 | 0 | 2 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
ClpP | 2 | 0 | 0 | 2 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
Transitional endoplasmic reticulum ATPase | 0 | 1 | 0 | 1 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
Parkin | 5 | 0 | 0 | 5 |
pyruvate kinase | 2 | 0 | 0 | 2 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
hexokinase-4 isoform 1 | 4 | 0 | 0 | 4 |
glucokinase regulatory protein | 4 | 0 | 0 | 4 |
Glutamate receptor 1 | 1 | 0 | 0 | 1 |
Glutamate receptor 3 | 1 | 0 | 0 | 1 |
Glutamate receptor 4 | 1 | 0 | 0 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 5 | 0 | 6 |
5-hydroxytryptamine receptor 1A | 0 | 5 | 2 | 7 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
D | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 4 | 0 | 4 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 1 | 3 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
beta-2 adrenergic receptor | 5 | 0 | 0 | 5 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 3 | 0 | 0 | 3 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 4 | 1 | 8 |
Beta-1 adrenergic receptor | 0 | 7 | 4 | 15 |
Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 2 | 2 |
Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
Beta-3 adrenergic receptor | 0 | 3 | 1 | 4 |
Vasopressin V1a receptor | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 3 | 1 | 4 |
Taste receptor type 2 member 38 | 0 | 0 | 2 | 3 |
Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Beta-2 adrenergic receptor | 0 | 1 | 5 | 6 |
Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
15-lipoxygenase, partial | 7 | 0 | 0 | 7 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | 0 | 0 | 1 | 1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | 0 | 0 | 1 | 1 |
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 3 | 0 | 3 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
Chain A, protease | 0 | 1 | 0 | 1 |
Chain B, protease | 0 | 1 | 0 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, Protease | 0 | 1 | 0 | 1 |
Chain B, Protease | 0 | 1 | 0 | 1 |
Chain A, Protease | 0 | 1 | 0 | 1 |
Chain B, Protease | 0 | 1 | 0 | 1 |
Chain A, Protease | 0 | 1 | 0 | 1 |
Chain B, Protease | 0 | 1 | 0 | 1 |
Chain A, PROTEASE RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, PROTEASE RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, Protease Retropepsin | 0 | 1 | 0 | 1 |
Chain B, Protease Retropepsin | 0 | 1 | 0 | 1 |
Chain A, Protease Retropepsin | 0 | 1 | 0 | 1 |
Chain B, Protease Retropepsin | 0 | 1 | 0 | 1 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Procathepsin L | 0 | 0 | 1 | 1 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Protease | 0 | 4 | 2 | 8 |
CAAX prenyl protease 1 homolog | 0 | 1 | 0 | 1 |
Plasmepsin V | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
Protease | 0 | 4 | 3 | 7 |
Neprilysin | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Thromboxane A2 receptor | 0 | 1 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Squalene synthase | 0 | 1 | 0 | 1 |
Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
Type-1 angiotensin II receptor | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
Dopamine beta-hydroxylase | 0 | 2 | 0 | 2 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 3 | 0 | 0 | 3 |
Toll-like receptor 4 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 3 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 2 | 4 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Folate receptor beta | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Folate receptor alpha | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Histidine decarboxylase | 0 | 1 | 0 | 1 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 1 | 0 | 2 | 1 | 5 |
Reduced folate transporter | 0 | 2 | 0 | 2 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Pteridine reductase 1 | 0 | 1 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 8 | 3 | 16 |
Glycine receptor subunit alpha-1 | 0 | 8 | 0 | 8 |
Glycine receptor subunit beta | 0 | 8 | 0 | 8 |
Glycine receptor subunit alpha-2 | 0 | 8 | 0 | 8 |
Glycine receptor subunit alpha-3 | 0 | 8 | 0 | 8 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Matrilysin | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 2 | 0 | 2 |
hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 1 | 0 | 1 |
Chain A, NAD-dependent deacetylase | 0 | 1 | 0 | 1 |
Poly [ADP-ribose] polymerase 2 | 0 | 1 | 0 | 1 |
NAD-dependent histone deacetylase SIR2 | 0 | 1 | 0 | 1 |
Coagulation factor VII | 0 | 1 | 0 | 1 |
Poly [ADP-ribose] polymerase 1 | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 2 | 0 | 2 |
NAD-dependent protein deacetylase HST2 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
NAD(+) hydrolase SARM1 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-6 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 2 | 0 | 2 |
Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Leukotriene B4 receptor 1 | 0 | 0 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 2 | 2 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit beta-4 | 0 | 1 | 0 | 1 |
Voltage-dependent P/Q-type calcium channel subunit alpha-1A | 0 | 1 | 0 | 1 |
Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-3 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent T-type calcium channel subunit alpha-1H | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit beta-3 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-7 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit beta-1 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-1 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit beta-2 | 0 | 1 | 0 | 1 |
Voltage-dependent R-type calcium channel subunit alpha-1E | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-4 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-3 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-8 subunit | 0 | 1 | 0 | 1 |
Bile acid receptor | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-6 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
Voltage-dependent T-type calcium channel subunit alpha-1I | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-4 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-5 subunit | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Chain H, Igg2b-kappa 40-50 Fab (heavy Chain) | 0 | 1 | 0 | 1 |
Chain L, Igg2b-kappa 40-50 Fab (light Chain) | 0 | 1 | 0 | 1 |
Chain A, Na, K-ATPase alpha subunit | 0 | 0 | 1 | 1 |
Kruppel-like factor 5 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
Serine hydroxymethyltransferase, mitochondrial | 0 | 1 | 0 | 1 |
CREB-binding protein | 1 | 0 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Alpha-synuclein | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 1 | 4 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 4 | 1 | 5 |
Progesterone receptor | 0 | 4 | 1 | 6 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Androgen receptor | 0 | 4 | 1 | 5 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 3 | 1 | 4 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 3-like | 0 | 1 | 0 | 1 |
DNA (cytosine-5)-methyltransferase 3A | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 9 | 0 | 1 | 0 | 1 |
ATP-sensitive inward rectifier potassium channel 11 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 3 | 3 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 3 | 1 | 4 |
Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
NADH-cytochrome b5 reductase 3 | 0 | 1 | 0 | 1 |
Thyroid peroxidase | 0 | 1 | 0 | 1 |
Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Multidrug resistance protein 1a | 0 | 0 | 0 | 1 |
Voltage-gated sodium channel Nav1.5 cardiac isoform | 0 | 1 | 0 | 1 |
Chain A, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
Chain A, Endothiapepsin | 0 | 1 | 0 | 1 |
Chain A, Endothiapepsin | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 0 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
P2Y purinoceptor 13 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Glycoprotein | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |